NCT05600062View on ClinicalTrials.gov

Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)

NARecruitingINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

January 17, 2026

Study Completion Date

June 15, 2026

Conditions

Acute Respiratory Distress Syndrome

Interventions

DRUG

Racecadotril 100 milligram (MG) Oral Capsule

Licensed NEP inhibitor

DRUG

Placebo

Placebo capsule

Trial Locations (1)

Unknown

RECRUITING

William Harvey Research Institute- Heart Centre, London

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

lead

Queen Mary University of London

OTHER

NCT05600062 - Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION) | Biotech Hunter | Biotech Hunter